𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Elevation of soluble interleukin-2 receptor in patients with non-small cell lung cancer treated with gefitinib

✍ Scribed by Shigenori Kanazawa; Kazuyuki Yamaguchi; Yoshimi Kinoshita; Yutaka Komiyama; Mikiko Muramatsu; Shosaku Nomura

Publisher
Springer-Verlag
Year
2006
Tongue
English
Weight
297 KB
Volume
132
Category
Article
ISSN
1432-1335

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

The impact of epidermal growth factor re
The impact of epidermal growth factor receptor gene status on gefitinib-treated Japanese patients with non-small-cell lung cancer
✍ Shuji Ichihara; Shinichi Toyooka; Yoshiro Fujiwara; Katsuyuki Hotta; Hisayuki Sh πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 French βš– 403 KB πŸ‘ 2 views

## Abstract We investigated the relationships between genetic factors and clinical outcome in Japanese non‐small‐cell lung cancer (NSCLC) patients treated with gefitinib. Ninety‐eight NSCLC patients who had been treated with gefitinib, were screened for mutations in epidermal growth factor receptor

Infections in patients with non-small-ce
Infections in patients with non-small-cell lung cancer treated with intensive induction chemotherapy
✍ Fuks, Joachim Z. ;Patel, Halesh ;Hornedo, Javier ;Van Echo, David A. ;Moody, Mar πŸ“‚ Article πŸ“… 1986 πŸ› John Wiley and Sons 🌐 English βš– 612 KB

The records of 65 consecutive patients with non-small-cell lung cancer (NSCLC) treated with intensive induction chemotherapy were reviewed to study the infectious complications during therapy and to analyze the relationship of the frequency of infections to various predisposing factors. A total of 4